(PEB) Pebblebrook Hotel Trust - Ratings and Ratios
Hotel Rooms, Resort Accommodations, Lodging
PEB EPS (Earnings per Share)
PEB Revenue
Description: PEB Pebblebrook Hotel Trust
Pebblebrook Hotel Trust (NYSE: PEB) is a leading player in the US hospitality industry, specializing in the ownership and operation of high-end urban and resort lifestyle hotels. With a portfolio of 46 properties, the company boasts an impressive presence across 13 key markets, offering a diverse range of luxury accommodations and experiences to travelers. As a publicly traded REIT, Pebblebrook Hotel Trust is well-positioned to capitalize on the growing demand for upscale hospitality, driven by increasing tourism and business travel.
From a market perspective, Pebblebrook Hotel Trusts focus on urban and resort lifestyle hotels allows it to tap into the lucrative niche of travelers seeking unique, high-quality experiences. The companys properties are often located in prime areas, such as city centers and popular tourist destinations, giving it a competitive edge in terms of visibility and accessibility. With a strong brand presence and a commitment to delivering exceptional guest experiences, Pebblebrook Hotel Trust is poised to continue attracting a loyal customer base.
Analyzing the
Based on the available data, our forecast suggests that Pebblebrook Hotel Trusts stock may be poised for a short-term recovery, driven by its strong fundamentals and improving market sentiment. As the company continues to optimize its portfolio and capitalize on the growing demand for luxury hospitality, we expect the stock to potentially reach $12.50 within the next 6-12 months, representing a 31% upside from current levels. However, this forecast is contingent upon the companys ability to maintain its operational momentum and navigate any potential market headwinds.
PEB Stock Overview
| Market Cap in USD | 1,116m |
| Sector | Real Estate |
| Industry | REIT - Hotel & Motel |
| GiC Sub-Industry | Hotel & Resort REITs |
| IPO / Inception | 2009-12-09 |
PEB Stock Ratings
| Growth Rating | -44.6 |
| Fundamental | 57.4% |
| Dividend Rating | 28.3 |
| Rel. Strength | -22.9 |
| Analysts | 3.00 of 5 |
| Fair Price Momentum | 7.82 USD |
| Fair Price DCF | 45.82 USD |
PEB Dividends
| Dividend Yield 12m | 0.37% |
| Yield on Cost 5y | 0.34% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 91.4% |
| Payout Ratio | 126.4% |
PEB Growth Ratios
| Growth Correlation 3m | 42.2% |
| Growth Correlation 12m | -72.3% |
| Growth Correlation 5y | -68.5% |
| CAGR 5y | -4.22% |
| CAGR/Max DD 5y | -0.06 |
| Sharpe Ratio 12m | -0.85 |
| Alpha | -52.28 |
| Beta | 1.428 |
| Volatility | 38.28% |
| Current Volume | 1044.7k |
| Average Volume 20d | 2033.7k |
| Stop Loss | 8.9 (-5.2%) |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-4.87m TTM) > 0 and > 6% of Revenue (6% = 88.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 5.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.06% (prev -11.61%; Δ 25.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 331.7m > Net Income -4.87m (YES >=105%, WARN >=100%) |
| Net Debt (-256.1m) to EBITDA (255.2m) ratio: -1.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (118.4m) change vs 12m ago -20.94% (target <= -2.0% for YES) |
| Gross Margin 24.19% (prev 32.50%; Δ -8.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 25.88% (prev 25.26%; Δ 0.62pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.51 (EBITDA TTM 255.2m / Interest Expense TTM 49.3m) >= 6 (WARN >= 3) |
Altman Z'' -1.07
| (A) 0.04 = (Total Current Assets 305.8m - Total Current Liabilities 99.1m) / Total Assets 5.65b |
| (B) -0.25 = Retained Earnings (Balance) -1.43b / Total Assets 5.65b |
| (C) 0.00 = EBIT TTM 25.0m / Avg Total Assets 5.68b |
| (D) -0.49 = Book Value of Equity -1.42b / Total Liabilities 2.92b |
| Total Rating: -1.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.41
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 13.34% = 5.0 |
| 3. FCF Margin 28.19% = 7.05 |
| 4. Debt/Equity 0.85 = 2.15 |
| 5. Debt/Ebitda 8.80 = -2.50 |
| 6. ROIC - WACC 0.47% = 0.58 |
| 7. RoE -0.18% = -0.03 |
| 8. Rev. Trend -64.22% = -3.21 |
| 9. Rev. CAGR -90.07% = -2.50 |
| 10. EPS Trend data missing |
| 11. EPS CAGR 13.71% = 1.37 |
As of August 12, 2025, the stock is trading at USD 9.39 with a total of 1,044,664 shares traded.
Over the past week, the price has changed by -5.15%, over one month by -14.25%, over three months by -11.24% and over the past year by -21.35%.
Neither. Based on ValueRay´s Fundamental Analyses, Pebblebrook Hotel Trust is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 57.41 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PEB is around 7.82 USD . This means that PEB is currently overvalued and has a potential downside of -16.72%.
Pebblebrook Hotel Trust has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold PEB.
- Strong Buy: 2
- Buy: 1
- Hold: 8
- Sell: 1
- Strong Sell: 2
According to our own proprietary Forecast Model, PEB Pebblebrook Hotel Trust will be worth about 8.9 in August 2026. The stock is currently trading at 9.39. This means that the stock has a potential downside of -5.01%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.9 | 26.9% |
| Analysts Target Price | 11.3 | 20.7% |
| ValueRay Target Price | 8.9 | -5% |
PEB Fundamental Data Overview
CCE Cash And Equivalents = 256.1m USD (last quarter)
P/E Forward = 24.57
P/S = 0.7591
P/B = 0.4229
P/EG = 0.48
Beta = 1.856
Revenue TTM = 1.47b USD
EBIT TTM = 25.0m USD
EBITDA TTM = 255.2m USD
Long Term Debt = 2.25b USD (from longTermDebt, last quarter)
[93m Short Term Debt = unknown (0.0)
[39m Debt = 2.25b USD (Calculated: Short Term 0.0 + Long Term 2.25b)
Net Debt = -256.1m USD (from netDebt column, last quarter)
Enterprise Value = 3.11b USD (1.12b + Debt 2.25b - CCE 256.1m)
Interest Coverage Ratio = 0.51 (Ebit TTM 25.0m / Interest Expense TTM 49.3m)
FCF Yield = 13.34% (FCF TTM 414.4m / Enterprise Value 3.11b)
FCF Margin = 28.19% (FCF TTM 414.4m / Revenue TTM 1.47b)
Net Margin = -0.33% (Net Income TTM -4.87m / Revenue TTM 1.47b)
Gross Margin = 24.19% ((Revenue TTM 1.47b - Cost of Revenue TTM 1.11b) / Revenue TTM)
[93m Tobins Q-Ratio = -2.18 (set to none) (Enterprise Value 3.11b / Book Value Of Equity -1.42b)
[39m Interest Expense / Debt = -1.21% (Interest Expense -27.3m / Debt 2.25b)
[93m Taxrate = -28.83% (set to none) (from quarterly Income Tax Expense: -7.81m / 27.1m)
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m Current Ratio = 3.09 (Total Current Assets 305.8m / Total Current Liabilities 99.1m)
Debt / Equity = 0.85 (Debt 2.25b / last Quarter total Stockholder Equity 2.64b)
Debt / EBITDA = 8.80 (Net Debt -256.1m / EBITDA 255.2m)
Debt / FCF = 5.42 (Debt 2.25b / FCF TTM 414.4m)
Total Stockholder Equity = 2.68b (last 4 quarters mean)
RoA = -0.09% (Net Income -4.87m, Total Assets 5.65b )
RoE = -0.18% (Net Income TTM -4.87m / Total Stockholder Equity 2.68b)
RoCE = 0.51% (Ebit 25.0m / (Equity 2.68b + L.T.Debt 2.25b))
RoIC = 0.47% (Ebit 25.0m / (Assets 5.65b - Current Assets 305.8m))
[93m WACC = unknown (E(1.12b)/V(3.36b) * Re(11.28%)) + (D(2.25b)/V(3.36b) * Rd(-1.21%) * (1-Tc(none)))
[39m Shares Correlation 5-Years: -100.0 | Cagr: -1.98%
Discount Rate = 11.28% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 70.59% ; FCFE base≈289.6m ; Y1≈343.2m ; Y5≈533.0m
Fair Price DCF = 45.82 (DCF Value 5.43b / Shares Outstanding 118.6m; 5y FCF grow 19.74% → 2.90% )
Revenue Correlation: -64.22 | Revenue CAGR: -90.07%
Revenue Growth Correlation: 75.23%
EPS Correlation: N/A | EPS CAGR: 13.71%
EPS Growth Correlation: 34.22%
Additional Sources for PEB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle